Solitary plasmacytoma of bone (SPB): observations from a randomized phase III trial that evaluated the additional of adjuvant systemic treatment to zoledronic acid (ZA) after definitive radiation (alliance A061402)

Douglas W. Sborov, Anuj K. Mahindra, Vera J. Suman, Elisabet Esteve Manasanch, Prashant Kapoor, Tibor Kovacsovics, Cesar Rodriguez, Benjamin Parsons, Jose Eugenio Najera, Lyle Goldman, Destin Carlisle, Yujia Wen, Shira H. Dinner, Ilene A. Galinsky, LeAnne Kennedy, James Omel, Philip McCarthy, Saad Usmani, Paul G. Richardson
Blood Cancer Journal · Springer Nature · 2026-11-16 · DOI: 10.1038/s41408-026-01674-w

Аннотация

Blood Cancer Journal, Published online: 16 November 2026; doi:10.1038/s41408-026-01674-w Solitary plasmacytoma of bone (SPB): observations from a randomized phase III trial that evaluated the additional of adjuvant systemic treatment to zoledronic acid (ZA) after definitive radiation (alliance A061402)

Читать у издателя →

Похожие статьи